Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2023 Filed May 15, 2023 21:05 UTC |
Olivo Alicia CGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 36,508 | $0.00 Strike: $19.65 | $0.00 |
DisclosureSEC source: 0001077183-23-000049 · wf-form4_168418469409508.xml · derivative · entry 8 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,508 Underlying: Common Stock · 36,508 shares Expires 2030-05-11 F7 · derivative.exercise_date: On May 11, 2023, Ms. Olivo was granted 36,508 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:59 UTC |
Olivo Alicia CGeneral Counsel
|
Tax withholdingCommon Stock | 662 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000032 · wf-form4_168314757102888.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,694 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2023 vesting of restricted stock. F2 · balance_after: This balance includes 357 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 17:04 UTC |
Kulkarni ShashikantChief Scientific Officer
|
Tax withholdingCommon Stock | 3,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000030 · wf-form4_168064226383246.xml · nonDerivative · entry 1 Kulkarni Shashikant · CIK 0001936800 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,673 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the April 1, 2023 vesting of restricted stock. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 22:34 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 117 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000025 · wf-form4_167788287257117.xml · nonDerivative · entry 2 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,765 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2023 vesting of restricted stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:34 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000025 · wf-form4_167788287257117.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,882 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2023 vesting of restricted stock. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:39 UTC |
Harris MelodyPresident, Enterprise Ops
|
GrantStock Option (Right to Buy) · Derivative | 201,613 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001077183-23-000003 · wf-form4_167287197105833.xml · derivative · entry 2 Harris Melody · CIK 0001880847 · President, Enterprise Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,613 Underlying: Common Stock · 201,613 shares Expires 2030-01-01 F2 · derivative.exercise_date: On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:39 UTC |
Harris MelodyPresident, Enterprise Ops
|
GrantCommon Stock | 108,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000003 · wf-form4_167287197105833.xml · nonDerivative · entry 1 Harris Melody · CIK 0001880847 · President, Enterprise Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,225 F1 · shares: On January 1, 2023, Ms. Harris was granted 108,225 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:40 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 959 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-23-000004 · wf-form4_167287199940591.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,762 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the December 31, 2022 vesting of restricted stock. Read SEC document |
| December 31, 2022 Filed Feb 1, 2023 22:37 UTC |
Sikri VishalPresident, Pharma Services
|
OtherCommon Stock | 225 | $7.04 | $1,584.00 |
DisclosureSEC source: 0001077183-23-000011 · wf-form5_167529103883294.xml · nonDerivative · entry 1 Sikri Vishal · CIK 0001931406 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,680 F1 · kind: These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2022. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 05, 2022 Filed Dec 8, 2022 01:47 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 249,169 | $0.00 Strike: $11.62 | $0.00 |
DisclosureSEC source: 0001077183-22-000202 · wf-form4_167046402051906.xml · derivative · entry 3 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,169 Underlying: Common Stock · 249,169 shares Expires 2029-12-05 F3 · derivative.exercise_date: On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023. Read SEC document |
| December 05, 2022 Filed Dec 8, 2022 01:47 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
GrantCommon Stock | 89,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000202 · wf-form4_167046402051906.xml · nonDerivative · entry 2 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,809 F2 · kind: On December 5, 2022, Mr. Sherman was granted an award of 89,206 shares of restricted stock. The shares subject to this award shall vest upon the achievement of an absolute total stockholder return of at least 20% for the period commencing December 7, 2022 and ending December 6, 2023. If such vesting condition is met, the shares subject to the award shall vest ratably over four years with the first tranche vesting on December 7, 2023. Read SEC document |
| December 05, 2022 Filed Dec 8, 2022 01:47 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
GrantCommon Stock | 44,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000202 · wf-form4_167046402051906.xml · nonDerivative · entry 1 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,603 F1 · kind: On December 5, 2022, Mr. Sherman was granted an award of 44,603 shares of restricted stock. The shares subject to this award shall vest ratably over four years with the first tranche vesting on December 7, 2023. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 02:23 UTC |
Stone WarrenPresident, Clinical Services
|
GrantStock Option (Right to Buy) · Derivative | 166,113 | $0.00 Strike: $11.21 | $0.00 |
DisclosureSEC source: 0001077183-22-000196 · wf-form4_167029339799719.xml · derivative · entry 2 Stone Warren · CIK 0001955295 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,113 Underlying: Common Stock · 166,113 shares Expires 2029-12-01 F2 · derivative.exercise_date: On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 02:23 UTC |
Stone WarrenPresident, Clinical Services
|
GrantCommon Stock | 89,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000196 · wf-form4_167029339799719.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,206 F1 · shares: On December 1, 2022, Mr. Stone was granted 89,206 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 22:13 UTC |
Perez David BrianDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,730 | $0.00 Strike: $7.34 | $0.00 |
DisclosureSEC source: 0001077183-22-000167 · wf-form4_166785917567279.xml · derivative · entry 2 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,730 Underlying: Common Stock · 9,730 shares Expires 2029-06-10 Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 22:13 UTC |
Perez David BrianDirector
|
GrantCommon Stock | 10,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000167 · wf-form4_166785917567279.xml · nonDerivative · entry 1 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 F1 · shares: On November 3, 2022, Mr. Perez was granted 10,300 restricted stock awards. These awards vest on June 10, 2023. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:16 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantCommon Stock | 13,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000157 · wf-form4_166751010713743.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,721 F1 · shares: On November 1, 2022, Ms. Dieter was granted 13,141 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 23:13 UTC |
Smith Christopher MChief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 694,444 | $0.00 Strike: $12.62 | $0.00 |
DisclosureSEC source: 0001077183-22-000148 · wf-form4_166077800532643.xml · derivative · entry 3 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,444 Underlying: Common Stock · 694,444 shares Expires 2029-08-15 F3 · derivative.exercise_date: On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 23:13 UTC |
Smith Christopher MChief Executive Officer
|
GrantCommon Stock | 265,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000148 · wf-form4_166077800532643.xml · nonDerivative · entry 2 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,219 F2 · shares: On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 23:13 UTC |
Smith Christopher MChief Executive Officer
|
GrantCommon Stock | 336,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000148 · wf-form4_166077800532643.xml · nonDerivative · entry 1 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,767 F1 · shares: On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:44 UTC |
Kulkarni ShashikantPresident of Lab Operations
|
GrantStock Option (Right to Buy) · Derivative | 51,653 | $0.00 Strike: $10.12 | $0.00 |
DisclosureSEC source: 0001077183-22-000127 · wf-form4_165956308168761.xml · derivative · entry 3 Kulkarni Shashikant · CIK 0001936800 · President of Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,653 Underlying: Common Stock · 51,653 shares Expires 2029-08-01 F3 · derivative.exercise_date: On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:44 UTC |
Kulkarni ShashikantPresident of Lab Operations
|
GrantCommon Stock | 24,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000127 · wf-form4_165956308168761.xml · nonDerivative · entry 1 Kulkarni Shashikant · CIK 0001936800 · President of Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,856 F1 · shares: On August 1, 2022, Dr. Kulkarni was granted 24,704 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:45 UTC |
Sholehvar DavidPresident, Clinical Services
|
GrantStock Option (Right to Buy) · Derivative | 25,826 | $0.00 Strike: $10.12 | $0.00 |
DisclosureSEC source: 0001077183-22-000128 · wf-form4_165956310295167.xml · derivative · entry 3 Sholehvar David · CIK 0001916426 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,826 Underlying: Common Stock · 25,826 shares Expires 2029-08-01 F3 · derivative.exercise_date: On August 1, 2022, Dr. Sholehvar was granted 25,826 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:45 UTC |
Sholehvar DavidPresident, Clinical Services
|
GrantCommon Stock | 12,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000128 · wf-form4_165956310295167.xml · nonDerivative · entry 1 Sholehvar David · CIK 0001916426 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,216 F1 · shares: On August 1, 2022, Dr. Sholehvar was granted 12,352 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 21:07 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000115 · wf-form4_165610486009377.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,580 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the June 22, 2022 vesting of restricted stock. Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:43 UTC |
Kelly Michael AaronDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000113 · wf-form4_165525379012128.xml · derivative · entry 4 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:43 UTC |
Kelly Michael AaronDirector
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000113 · wf-form4_165525379012128.xml · nonDerivative · entry 1 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,419 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:43 UTC |
KANOVSKY STEPHEN MDirector
|
GrantStock Options (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000112 · wf-form4_165525376524354.xml · derivative · entry 5 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:43 UTC |
KANOVSKY STEPHEN MDirector
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000112 · wf-form4_165525376524354.xml · nonDerivative · entry 1 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,754 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
CROWTHER BRUCE KDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000111 · wf-form4_165525374002565.xml · derivative · entry 3 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
CROWTHER BRUCE KDirector
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000111 · wf-form4_165525374002565.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,120 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
HANNAH ALISON L.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000110 · wf-form4_165525372464364.xml · derivative · entry 6 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
HANNAH ALISON L.Director
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000110 · wf-form4_165525372464364.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,433 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
Stahler Rachel ADirector
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000109 · wf-form4_165525370625141.xml · derivative · entry 4 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:42 UTC |
Stahler Rachel ADirector
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000109 · wf-form4_165525370625141.xml · nonDerivative · entry 1 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,335 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:41 UTC |
Daly DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000108 · wf-form4_165525367136668.xml · derivative · entry 3 Daly David · CIK 0001320267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:41 UTC |
Daly DavidDirector
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000108 · wf-form4_165525367136668.xml · nonDerivative · entry 1 Daly David · CIK 0001320267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,179 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:41 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,882 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001077183-22-000107 · wf-form4_165525365169698.xml · derivative · entry 7 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,882 Underlying: Common Stock · 13,882 shares Expires 2029-06-10 Read SEC document |
| June 10, 2022 Filed Jun 15, 2022 00:41 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 15,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000107 · wf-form4_165525365169698.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,667 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:31 UTC |
Sikri VishalPresident and CCO, Inivata
|
GrantStock Option (Right to Buy) · Derivative | 319,112 | $0.00 Strike: $8.42 | $0.00 |
DisclosureSEC source: 0001077183-22-000091 · wf-form4_165420906324475.xml · derivative · entry 2 Sikri Vishal · CIK 0001931406 · President and CCO, Inivata 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,112 Underlying: Common Stock · 319,112 shares Expires 2029-06-01 F3 · derivative.exercise_date: On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date. F4 · derivative.exercise_date: On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:31 UTC |
Sikri VishalPresident and CCO, Inivata
|
GrantCommon Stock | 148,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000091 · wf-form4_165420906324475.xml · nonDerivative · entry 1 Sikri Vishal · CIK 0001931406 · President and CCO, Inivata 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,455 F1 · shares: On June 1, 2022, Mr. Sikri was granted 89,073 restricted stock awards. These awards vest ratably over the first two anniversary dates of the grant date. F2 · shares: On June 1, 2022, Mr. Sikri was granted 59,382 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:08 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,334 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-22-000087 · wf-form4_165308090690889.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,334 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 21:08 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 3,334 | $7.27 | $24,238.18 |
DisclosureSEC source: 0001077183-22-000087 · wf-form4_165308090690889.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2022 Filed May 2, 2022 21:46 UTC |
Bonello WilliamChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,727 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-22-000071 · wf-form4_165152792439687.xml · derivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,727 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| April 28, 2022 Filed May 2, 2022 21:46 UTC |
Bonello WilliamChief Financial Officer
|
Exercise / conversionCommon Stock | 5,727 | $7.52 | $43,067.04 |
DisclosureSEC source: 0001077183-22-000071 · wf-form4_165152792439687.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 23:07 UTC |
Brown Douglas MatthewChief Strategy Officer
|
GrantCommon Stock | 82,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000054 · wf-form4_164911361608506.xml · nonDerivative · entry 1 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,684 F1 · shares: On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 23:08 UTC |
Bonello WilliamChief Financial Officer
|
GrantCommon Stock | 82,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000056 · wf-form4_164911365676278.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,821 F1 · shares: On April 1, 2022, Mr. Bonello was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 23:07 UTC |
Sholehvar DavidPresident, Clinical Services
|
GrantStock Option (Right to Buy) · Derivative | 66,372 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001077183-22-000055 · wf-form4_164911363482493.xml · derivative · entry 2 Sholehvar David · CIK 0001916426 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,372 Underlying: Common Stock · 66,372 shares Expires 2029-04-01 F2 · derivative.exercise_date: On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 23:07 UTC |
Sholehvar DavidPresident, Clinical Services
|
GrantCommon Stock | 30,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000055 · wf-form4_164911363482493.xml · nonDerivative · entry 1 Sholehvar David · CIK 0001916426 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,864 F1 · shares: On April 1, 2022, Dr. Sholehvar was granted 30,864 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 23:02 UTC |
Bonello WilliamChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · derivative · entry 3 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,727 Underlying: Common Stock · 5,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.